EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

An Investigation into the Use of Stimulant Therapy during Pregnancy

Natalie Shields, Rexford Muza, Christopher Kosky, Adrian J Williams

Sleep Disorders · 2012

DOI: 10.1155/2012/308952 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Sleep Disorders, 2012. Verfasst von Natalie Shields und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, King's College London, London WC2R 2LS, UK ; Sleep Disorders Centre, St Thomas' Hospital, London SE1 7EH, UK. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

A lack of documentation of stimulant use during pregnancy means that doctors have difficulty advising narcoleptic and hypersomnolent patients.

Objectives

To investigate the use of stimulant therapy in narcoleptic and hypersomnolent patients during pregnancy.

Method

A search of clinic letters at a tertiary sleep clinic identified women who became pregnant whilst receiving stimulant therapy between 01/09/1999 and 18/11/2010. Fifteen patients were included in a telephone survey.

Results

There were 20 pregnancies. The reported advice received with regards to stimulant use was variable. In 7 pregnancies, medication was stopped preconceptually: 1 had a cleft palate and an extra digit 6 had good foetal outcomes. In 8 pregnancies, medication was stopped postconceptually: 1 had autism and attention-deficit hyperactivity disorder; 7 had good foetal outcomes. In 5 pregnancies, medication was continued throughout pregnancy: 2 ended in miscarriage; 1 was ectopic; 2 had good foetal outcomes. The most common symptom experienced was debilitating hypersomnolence.

Conclusion

There are no standardised guidelines for use of stimulants during pregnancy. Women have significant symptoms during pregnancy for which there is an unmet clinical need. More research is needed into whether medication can be safely continued during pregnancy, and if not, when it should be discontinued. Better standardized advice should be made available.

Autor:innen und Institutionen

  • School of Medicine, King's College London, London WC2R 2LS, UK ; Sleep Disorders Centre, St Thomas' Hospital, London SE1 7EH, UK.

Zitieren

APA

Shields, N., Muza, R., Kosky, C., & Williams, A. J. (2012). An Investigation into the Use of Stimulant Therapy during Pregnancy. Sleep Disorders. https://doi.org/10.1155/2012/308952

Vancouver

Shields N, Muza R, Kosky C, Williams AJ. An Investigation into the Use of Stimulant Therapy during Pregnancy. Sleep Disorders. 2012. doi:10.1155/2012/308952

BibTeX
@article{Shields2012,
  author = {Shields, Natalie and Muza, Rexford and Kosky, Christopher and Williams, Adrian J},
  title = {An Investigation into the Use of Stimulant Therapy during Pregnancy},
  journal = {Sleep Disorders},
  year = {2012},
  doi = {10.1155/2012/308952}
}
Kostenlos starten →